ESMO 2025: Bayer and BI close in first line HER2+ NSCLC
ESMO 2025: Bayer and BI Report Similar Efficacy Outcomes Bayer and BI have reported similar efficacy outcomes for sevabertinib and Hernexeos in HER2-mutant NSCLC. At the European So…
ESMO 2025: Bayer and BI Report Similar Efficacy Outcomes Bayer and BI have reported similar efficacy outcomes for sevabertinib and Hernexeos in HER2-mutant NSCLC. At the European So…
US Appeals Court Ruling on Data Breach Lawsuits The 4th Circuit Court has lowered the burden of proof for data breach lawsuits, ruling tha…
World's Largest Agnostic Autonomous Haulage Project Nears Completion The world's largest fully agnostic autonomous mine project is closing…
Canada to Fast-Track Critical Minerals Projects Canada will fast-track critical minerals projects valued at C$6.4bn ($4.56bn) as part of t…
11 Tasty and Easy to Grow Squash Varieties Choosing the right squash variety for next season can help you grow an exceptional crop. Select…
12 Best Performing Stocks in the Last 3 Months On Friday, October 31, shares of tech giant Amazon.com, Inc. (AMZN) boosted the market afte…
What Does It Say About a Miles Teller Hosted 'SNL' That Shane Gillis Is a Highlight? By Dustin Rowles | TV | November 2, 2025
2025 GLAMOUR Beauty Awards Winners Announced The winners of the 2025 GLAMOUR Beauty Awards have been announced, and we are thrilled to sha…